Guru Ownership Trend
Guru Analysis for Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. (ANIK), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $7.91 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $151,578.44 net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 3.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Anika Therapeutics, Inc. (ANIK)
Major holders include Renaissance Technologies (RenTech) ($4.96 M), Cliff Asness ($665,781), Steven Cohen ($558,370). According to the latest reported data, 3 tracked investment managers collectively hold approximately 643,100 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $151,578.44, with 2 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited ANIK. The total reported sell value was $597,232.99.
Yes, 1 managers opened new positions in ANIK, and 1 increased their existing holdings. The total reported buy value was $748,811.43.